Renal transplantation in autosomal dominant polycystic kidney disease
- 17 June 2014
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Nephrology
- Vol. 10 (8), 455-465
- https://doi.org/10.1038/nrneph.2014.104
Abstract
In patients with autosomal dominant polycystic kidney disease (ADPKD) evaluated for kidney transplantation, issues related to native nephrectomy, cystic liver involvement, screening for intracranial aneurysms and living-related kidney donation deserve special consideration. Prophylactic native nephrectomy is restricted to patients with a history of cyst infection or recurrent haemorrhage or to those in whom space must be made to implant the graft. Patients with liver involvement require pretransplant imaging. Selection of patients for pretransplant screening of intracranial aneurysms should follow the general recommendations for patients with ADPKD. In living related-donor candidates aged <30 years and at-risk of ADPKD, molecular genetic testing should be carried out when ultrasonography and MRI findings are normal or equivocal. After kidney transplantation, patient and graft survival rates are excellent and the volume of native kidneys decreases. However, liver cysts continue to grow and treatment with a somatostatin analogue should be considered in patients with massive cyst involvement. Cerebrovascular events have a marginal effect on post-transplant morbidity and mortality. An increased risk of new-onset diabetes mellitus and nonmelanoma skin cancers has been reported, but several studies have challenged these findings. Finally, no data currently support the preferential use of mammalian target of rapamycin inhibitors as immunosuppressive agents in transplant recipients with ADPKD.Keywords
This publication has 147 references indexed in Scilit:
- Polycystic Liver Diseases: Congenital Disorders of Cholangiocyte SignalingGastroenterology, 2011
- Management of ESRD in Patients With Autosomal Dominant Polycystic Kidney DiseaseAdvances in Chronic Kidney Disease, 2010
- Molecular diagnostics for autosomal dominant polycystic kidney diseaseNature Reviews Nephrology, 2010
- Polycystic Liver DiseaseAnnals of Surgery, 2009
- Autosomal dominant polycystic kidney disease: the last 3 yearsKidney International, 2009
- Cardiovascular abnormalities in autosomal-dominant polycystic kidney diseaseNature Reviews Nephrology, 2009
- Polycystic Kidney DiseaseAnnual Review of Medicine, 2009
- Evaluating the clinical utility of a molecular genetic test for polycystic kidney diseaseMolecular Genetics and Metabolism, 2007
- Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: Contribution of extrarenal complications to mortalityAmerican Journal of Kidney Diseases, 2001
- Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1The Lancet, 1994